Abbott Gains US Approval For Pro Version Of Flash Glucose System
Executive Summary
The FreeStyle Libre Pro is intended to provide health-care providers with an easy-to-read visual summary of a diabetic patient's glucose data. Abbott has also filed for approval with FDA for a consumer-targeted version of the device.
You may also be interested in...
#ADA2017: On Visual Learning, Standardization, Data And More Data
The 77th American Diabetes Association conference, held June 9-13 in San Diego, attracted more than 16,000 attendees from 120 countries and featured more than 2,500 presentations. Medtech Insight had its ear close to the ground at the meeting, posting Tweets on major clinical trial data updates, as well as insights on the latest trends and innovations in the field. This article rounds up the best of the Tweets and includes updates from key diabetes management players including Abbott, Medtronic, Senseonics and Dexcom.
US Approvals Analysis: Strong Q3 For Metabolic-Disease Devices
Of the five original PMAs approved last month by US FDA, two target diabetes and one targets obesity. In addition, the agency granted a de novo classification to another obesity device. Overall, FDA had a productive third-quarter for approvals and clearances.
US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G
The hybrid closed-loop automated insulin delivery system, the first closed-loop system approved anywhere in the world, automatically monitors glucose and provides appropriate basal insulin doses in people with type 1 diabetes.